Resistance trends in Neisseria gonorrhoeae in Southwestern Ohio

Sexually Transmitted Diseases

Volumn 37, Issue 2, 2010, Pages 121-122

  Herchline, Thomas E ^a,b   Inkrott, Bradley P ^c  

^a WRIGHT STATE UNIVERSITY   (United States)

^b Montgomery County Public Schools   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PUBLIC HEALTH; UNITED STATES;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; FEMALE; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; OHIO; TETRACYCLINE;

EID: 77649166364     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181be356e     Document Type: Article

References (11)

1. Iverson CJ, Wang SA, Lee MV, et al. Fluoroquinolone resistance among Neisseria gonorrhoeae isolates in Hawaii, 1990-2000: Role of foreign importation and increasing endemic spread. Sex Transm Dis 2004; 31:702-708.
2. Bauer HM, Mark KE, Samuel M, et al. Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000 -2003. Clin Infect Dis 2005; 41:795-803
3. Centers for Disease Control and Prevention (CDC). Update to CDC?s sexually transmitted diseases treatment guidelines, 2006: Fluoroquinolones no longer recommended for treatment of gonococ-cal infections. MMWR Morb Mortal Wkly Rep 2007; 56:332-336.
4. AB Biodisk. Etest for antimicrobial susceptibility testing. Solna, Sweden. Available at: http://www.abbiodisk.com/pdf/pi/75002288. Accessed on 31 July 2009.
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Clinical and Laboratory Standards Institute. Wayne, PA, 2007. M100-S17, 27.
6. Wang S, Harvey AB, Conner S, et al. Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: The spread of fluoroquinolone resistance. Ann Intern Med 2007; 147: 81-88.
7. Kampmeier RH. Introduction of sulfonamide therapy for gonorrhea. Sex Transm Dis 1983; 10:81-84.
8. Moran JS. Treating uncomplicated Neisseria gonorrhoeae infections: Is the anatomic site of infection important? Sex Transm Dis 1995; 22:39-47.
9. Macomber KE, Boehme MS, Rudrik JT, et al. Drug-resistant Neisseria gonorrhoeae in Michigan. Emerg Infect Dis 2005; 11:1009-1015.
10. Dicker LW, Mosure DJ, Steece R, et al. Gonorrhea prevalence and coinfection with Chlamydia in women in the United States, 2000. Sex Transm Dis 2003; 30:472-476.
11. Vendor Newman LM, Moran JS, Workowski KA. Update on the management of gonorrhea in adults in the United States. Clin Infect Dis 2007; 44(suppl 3):S84-S101.